UnknownNot applicableNCT01842555

Photodynamic Therapy (PDT) Oncology Registry

The data elements for the PDT Registry project include virtually all the elements in the standard hospital-based cancer registry record, although in some cases at a finer level of detail. All data points should be found in the participant's medical record. The principal difference between the PDT Registry data set and that collected by the registries is the inclusion of more information specific to PDT.

Checked against the public recordLast updated Aug 24, 2018 · Source: ClinicalTrials.gov

StatusUnknown
PhaseNot applicable
U.S. locations1
SponsorMain Line Health
01
Study overview

What this study is about

Purpose
Not specified
Study type
Observational
Phase
Not applicable
Sponsor
Main Line Health
Interventions being studied
Other: Registry
02
Explore related studies

How this study is categorized

These labels come from structured fields and exact terms in the public record.

03
Public criteria

Who may be able to participate

Inclusion Criteria: * 18 years of age or older, male or female, diagnosed with cancer and is undergoing or has undergone Photodynamic Therapy (PDT). * Patients must have undergone PDT with Photofrin® at a participating institution. * Patients scheduled to undergo PDT with Photofrin® * Cancer patients receiving some or all primary care (e.g.,cancer-directed surgery, systemic therapy, radiation therapy, palliative care)in the participating institution. * Cancer patients with a history of any type of cancer who have been no evidence of disease(for five years but without a history of distant metastases or evidence of relapse if they meet the previous criteria). Exclusion Criteria: * Cancer patients who present to the participating institution with a diagnosis of a simultaneous second primary. * Cancer patients receiving all primary cancer care (e.g., cancer-directed surgery, chemotherapy, targeted therapy, radiation therapy, palliative care) outside of participating institution. * Patients treated with photosensitizers other than Photofrin®

Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.

04
Study sites

U.S. locations

  • Main Line Health, Lankenau Medical CenterWynnewood, Pennsylvania

Source and freshness
Processed from ClinicalTrials.gov. Last public update: Aug 24, 2018. Always confirm current availability with the study team.

View original record ↗